PwC Pins Blame On Valeant In Securities Fraud Suit
PricewaterhouseCoopers fought back against a special master's refusal to recommend tossing a securities fraud claim brought by investors of the former Valeant Pharmaceuticals International Inc., arguing it is a victim of...To view the full article, register now.
Already a subscriber? Click here to view full article